A1RG34:BVMF
Argenx Se Bdr
201,80Ā BRL
0,00%
(0,00) 1Ā D
5. nov., 12:25:06 GMT-3 · BRL
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for A1RG34Ā ā¦
Markedsverdi
59,67Ā mrd.
Snittvolum
38,00
Volum
0,00
52Ā u hĆøy
213,15Ā BRL
52Ā u lav
143,22Ā BRL
UtestƄende aksjer
62,89Ā mill.
Antall ansatte
2k
Markedsverdi
59,67Ā mrd.
Snittvolum
38,00
Volum
0,00
52Ā u hĆøy
213,15Ā BRL
52Ā u lav
143,22Ā BRL
UtestƄende aksjer
62,89Ā mill.
Antall ansatte
2k
Nyhetssaker
Fra nettkilder og nyhetspartnere
Investing.com
·
for 16 timer siden
argenx reports positive phase 3 data for autoimmune myositis drug
Profil
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
Om Argenx Se Bdr
Administrerende direktĆør-
Ansatte1,86k
Grunnlagt25. apr. 2008
Hovedkontor-
SektorHealth Care
Bransje-
Nettstedargenx.com